Oct 9, 2013
Novel Therapeutic Opportunity in Narcolepsy
It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy".
Aerial Biopharma Announces Positive Results For ADX-N05 202; A Phase 2b Trial For Narcolepsy
Aerial BioPharma, which has several Chattanooga investors, announced on Tuesday positive results from a Phase 2b clinical study of ADX-N05 in patients with Excessive Daytime Sleepiness associated with narcolepsy.
Company sale gets nearer for Aerial BioPharma?
The compound is intended to treat patients with the excessive daytime sleepiness associated with narcolepsy, and the preliminary results are "remarkable," says Todd Swick , clinical investigator and professor at the University of Texas School of Medicine-Houston.
Hypersomnia can be a nightmare - Tue, 10 Sep 2013 PST
Imagine what it would be like if you could fall asleep anywhere at any time. What if this included difficulty staying awake while driving, talking to someone or working? At any given time, 4 to 6 percent of people face this problem.